AFT introduces new HYLO-FRESH and HYLO-FORTE

AFT Pharmaceuticals is pleased to announce the launch of new HYLO®-FRESH and HYLO- FORTE® eye drops to the Australasian market.

These preservative-free and phosphate-free eye drops are delivered in a unique medical device that provides an ingenious new solution for the treatment of dry eye, severe and chronic cases of dry eye, or post-surgery.

The patented COMOD® bottle is an air-less multi-dose application system that ensures the precise delivery of at least 300 sterile and preservative-free drops in each 10ml pack. HYLO®-FRESH utilises high quality sodium hyaluronate (0.1%) to provide effective and long-lasting lubrication for dry eyes of moderate to medium severity.

HYLO-FORTE® is formulated with an elevated concentration of sodium hyaluronate (0.2%) producing a high viscosity product that provides more intensive lubrication of severe or chronic cases of dry eye, without vision impairment. It is also suitable for use following surgery. HYLO®- FRESH and HYLO-FORTE® eye drops both have a use-up period of six months after opening, and are compatible with all contact lenses.

May 1, 2024

AFT Licenses Maxigesic® IV in Brazil

We are delighted to announce our partnership with Brazil’s Halex Istar, and to be exclusively responsible for distributing its Maxigesic IV in Brazi…

Read More

April 24, 2024

AFT, Massey Ventures, Gilles McIndoe to develop scar treatment

AFT collaborate with Massey Ventures and Gilles McIndoe to begin the development of a topical treatment for keloid and hypertrophic scarring….

Read More

March 5, 2024

AFT makes further progress in international markets

AFT Pharmaceuticals provides an update on recent progress it has made in international markets….

Read More